| ARCHETYPE ID | openEHR-EHR-OBSERVATION.charlson_comorbidity_index.v2 |
|---|---|
| Concept | Charlson Comorbidity Index (CCI) |
| Description | An assessment tool used to predict the risk of death from comorbid disease. |
| Use | To record the result for each component parameter of the Charlson Comorbidity Index (CCI) and its total sum, and to calculate the 10 year estimated survival. This data and value set is from the original Charlson et al study in 1987. In the original paper, 19 'conditions' were represented, including a number that had separate representations of the same condition, but with different severity. In this archetype, these conditions have been grouped together - for example, 'Mild liver disease' and 'Moderate to severe liver disease' are values under the condition 'Liver disease'. As a result, there are only 16 conditions represented in this archetype. |
| Purpose | To record the result for each component parameter of the Charlson Comorbidity Index (CCI) and its total sum, and to calculate the 10 year estimated survival. |
| References | Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83. doi: 10.1016/0021-9681(87)90171-8. PubMed PMID: 3558716. Available from: https://www.sciencedirect.com/science/article/pii/0021968187901718?via%3Dihub. |
| Copyright | © openEHR Foundation |
| Authors | Author name: Liv Laugen Organisation: Oslo universitetssykehus Email: liv.laugen@ous-hf.no |
| Other Details Language | Author name: Liv Laugen Organisation: Oslo universitetssykehus Email: liv.laugen@ous-hf.no |
| Other Details (Language Independent) |
|
| Keywords | CCI, comorbidity, concurrent conditions, estimated survival, mortality, prognosis, assessment, risk |
| Lifecycle | published |
| UID | 3bba47ec-ca74-434f-b0db-1257dbf945b8 |
| Language used | en |
| Citeable Identifier | 1246.145.2940 |
| Revision Number | 2.0.0 |
| protocol | |
| Extension | Extension: Additional information required to extend the model with local content or to align with other reference models or formalisms. For example: local information requirements; or additional metadata to align with FHIR. Include: All not explicitly excluded archetypes |
| data | |
| Age group | Age group: The age category of the patient. 0: <50 years 1: 50–59 years 2: 60-69 years 3: 70–79 years 4: ≥80 years |
| Myocardial infarction | Myocardial infarction: 0: No 1: Yes [History of definite or probable Myocardial infarction (EKG changes and/or enzyme changes).] |
| Congestive heart failure | Congestive heart failure: 0: No 1: Yes [Exertional or paroxysmal nocturnal dyspnea and has responded to symptomatically (or on physical examination) to digitalis, diuretics, or afterload reducing agents.] |
| Peripheral vascular disease | Peripheral vascular disease: 0: No 1: Yes [Intermittent claudication or past bypass for chronic arterial insufficiency, history of gangrene or acute arterial insufficiency, or untreated thoracic or abdominal aneurysm (≥6 cm).] |
| Cerebrovascular disease | Cerebrovascular disease: 0: No 1: Yes [History of a cerebrovascular accident (CVA) with minor or no residua and transient ischemic attacks (TIA).] |
| Dementia | Dementia: 0: No 1: Yes [Dementia or chronic cognitive deficit.] |
| Chronic pulmonary disease | Chronic pulmonary disease: 0: No 1: Yes [Mild or moderat or severe chronic pulmonary disease.] |
| Ulcer disease | Ulcer disease: 0: No 1: Yes [Any history of treatment for ulcer disease or history of ulcer bleeding, or history of gastrointestinal bleeding requiring transfusions from causes other than ulcer disease.] |
| Liver disease | Liver disease: 0: None 1: Mild [Cirrhosis without portal hypertension or chronic hepatitis.] 3: Moderate to severe [Moderate: cirrhosis with portal hypertension, but without bleeding. Severe: cirrhosis with portal hypertension and a history of variceal bleeding.] |
| Connective tissue disease | Connective tissue disease: 0: No 1: Yes |
| Diabetes mellitus | Diabetes mellitus: 0: None or diet-controlled 1: Uncomplicated [Diabetes treated with insulin or oral hypoglycemics, but not diet alone.] 2: End-organ damage [Diabetes with end organ damage.] |
| Hemiplegia | Hemiplegia: 0: No 2: Yes |
| Moderate or severe renal disease | Moderate or severe renal disease: 0: No 2: Yes [Moderate: creatinine >3 mg/dL (0.27 mmol/L). Severe: on dialysis, status post kidney transplant, uremia.] |
| Solid tumor | Solid tumor: 0: None 2: Localized [Solid tumor without documented metastases.] 6: Metastatic [Metastatic solid tumor.] |
| Leukemia | Leukemia: 0: No 2: Yes |
| Lymphoma | Lymphoma: 0: No 2: Yes |
| AIDS | AIDS: 0: No 6: Yes [Patients with define or probable AIDS, i.e. AIDS related complex.] |
| CCI total score | CCI total score: The total sum of each component variable for the Charlson Comorbidity Index. |
| Estimated 10-year survival | Estimated 10-year survival: The predicted 10-year survival rate. Property: Qualified real Units: % |
| events | |
| Any event | Any event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time. |
| Other contributors | Stein Arne Rimehaug, Sunnaas sykehus, Norway Vebjørn Arntzen, Oslo University Hospital, Norway (openEHR Editor) Silje Ljosland Bakke, Helse Vest IKT AS, Norway (openEHR Editor) SB Bhattacharyya, Bhattacharyyas Clinical Records Research & Informatics LLP, India Hugo Claudio Briceño García, Catsalut, Spain Ian Bull, ACT Health, Australia Stefan Dubois, Dep't of Pathology and Genetics, University Hospitals of Lund and Malmö, Sweden Heather Grain, Llewelyn Grain Informatics, Australia Mikkel Johan Gaup Grønmo, Helse Nord IKT, Norway (openEHR Editor) Elin Hallan Naderi, OUS, Norway Amanda Herbrand, University Hospital Basel, Switzerland Evelyn Hovenga, EJSH Consulting, Australia Anjali Kulkarni, Karkinos, India Jörgen Kuylenstierna, eWeave AB, Sweden Liv Laugen, Oslo University Hospital, Norway, Norway (openEHR Editor) Darin Leonhardt, PLRI, Germany Heather Leslie, Atomica Informatics, Australia (openEHR Editor) Michael Lutz, BITsoft, Germany Terje Nordberg, Helse Bergen, Norway Mikael Nyström, Cambio Healthcare Systems AB, Sweden Bjørn Næss, DIPS ASA, Norway Helge Pettersen, Helse Bergen, Norway Ragnhild Schultz, OUS, Norway Benjamin Senst, Germany Natalia Strauch, Medizinische Hochschule Hannover, Germany Olav Thorsen, Stavanger University Hospital, Norway John Tore Valand, Helse Bergen, Norway (openEHR Editor) Marit Alice Venheim, Helse Vest IKT, Norway (openEHR Editor) Henriette Krogh, Helsedirektoratet, Norway Hanne Marte Bårholm, Helse Vest IKT, Norway (Nasjonal IKT redaktør) |
| Translators |
|